Equine herpesvirus-1 is a highly prevalent and frequently pathogenic infection of equids. The most serious clinical consequences of infection are abortion and equine herpesvirus myeloencephalopathy (EHM). In recent years, there has been an apparent increase in the incidence of EHM in North America, with serious consequences for horses and the horse industry. This consensus statement draws together current knowledge in the areas of pathogenesis, strain variation, epidemiology, diagnostic testing, vaccination, outbreak prevention and control, and treatment.Key words: Abortion; Horse; Immunology; Infectious diseases; Myeloencephalopathy; Respiratory tract; Viral.E quine herpesvirus-1 (EHV-1) infection is ubiquitous in most horse populations throughout the world, and causes disease in horses and extensive economic losses through frequent outbreaks of respiratory disease, abortion, neonatal foal death, and myeloencephalopathy. [1][2][3][4] Infections caused by EHV-1 are particularly common in young performance horses, and typically result in establishment of latent infection within the 1st weeks or months of life 5 with subsequent viral reactivation causing clinical disease and viral shedding during periods of stress. The relevant effects of this virus on the equine population are 3-fold. Firstly, sporadic occurrence of mild respiratory disease associated with pyrexia, principally affecting horses under 2 years of age, can lead to interruptions in athletic training programs; this is economically the least important manifestation of EHV-1 disease. Secondly, abortion occurring during the 3rd trimester of pregnancy, results in important economic losses. Thirdly, outbreaks of neurological disease (equine herpes myeloencephalopathy or EHM) cause suffering and loss of life and also lead to extensive movement restrictions, disrupting breeding or training schedules and causing management difficulties at training centers, racetracks, and horse events. A perceived increase in the incidence of EHM outbreaks in North America in recent years has led to the proposal that it could represent an emerging disease threat. 6 The recent increased impact of EHM in North America provided the impetus for this consensus statement. The renewed focus on EHV-1 infection and its control, new developments in our understanding of this virus and its behavior in horses, and the development of new viral detection technologies have resulted in renewed challenges for clinicians in responding to the threat of EHV-1 and to outbreaks. In an attempt to address this challenge, this statement is structured as a series of critical questions, which we believe capture the key challenges for equine clinicians and scientists. The responses seek to distill current evidence-based knowledge
Abbreviations:CTL cytotoxic T-lymphocyte EHM equine herpesvirus myeloencephalopathy EHV-1 equine herpesvirus-1 Consensus Statements of the American College of Veterinary Internal Medicine (ACVIM) provide the veterinary community with up-to-date information on the pathophysiolo...